Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax combinations in relapsed/refractory follicular lymphoma
NCT02187861Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of venetoclax in follicular lymphoma (FL), sponsored by Roche. Started Dec 2014; status: completed.
02
Drugs
venetoclax
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02187861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187861.